Free Trial

Ontrak (OTRK) Competitors

Ontrak logo
$1.82 -0.01 (-0.55%)
(As of 11/22/2024 ET)

OTRK vs. MRAI, CCM, PMD, OPGN, TOI, BRTX, ATIP, MGRX, KDLY, and ATPC

Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Marpai (MRAI), Concord Medical Services (CCM), Psychemedics (PMD), OpGen (OPGN), Oncology Institute (TOI), BioRestorative Therapies (BRTX), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), Kindly MD (KDLY), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry.

Ontrak vs.

Ontrak (NASDAQ:OTRK) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation.

Ontrak has higher earnings, but lower revenue than Marpai. Marpai is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ontrak$11.24M0.68-$27.92M-$10.62-0.17
Marpai$37.15M0.53-$28.75M-$2.64-0.54

Ontrak has a beta of 2.59, meaning that its share price is 159% more volatile than the S&P 500. Comparatively, Marpai has a beta of 4.69, meaning that its share price is 369% more volatile than the S&P 500.

Ontrak currently has a consensus target price of $45.00, indicating a potential upside of 2,372.53%. Marpai has a consensus target price of $6.00, indicating a potential upside of 322.54%. Given Ontrak's higher probable upside, research analysts clearly believe Ontrak is more favorable than Marpai.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ontrak
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

12.9% of Ontrak shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 1.9% of Ontrak shares are owned by insiders. Comparatively, 61.3% of Marpai shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Ontrak received 36 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 59.38% of users gave Ontrak an outperform vote.

CompanyUnderperformOutperform
OntrakOutperform Votes
38
59.38%
Underperform Votes
26
40.63%
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

Marpai has a net margin of -85.70% compared to Ontrak's net margin of -237.77%. Marpai's return on equity of 0.00% beat Ontrak's return on equity.

Company Net Margins Return on Equity Return on Assets
Ontrak-237.77% -171.34% -113.42%
Marpai -85.70%N/A -100.23%

In the previous week, Marpai had 1 more articles in the media than Ontrak. MarketBeat recorded 2 mentions for Marpai and 1 mentions for Ontrak. Marpai's average media sentiment score of 0.60 beat Ontrak's score of -3.00 indicating that Marpai is being referred to more favorably in the news media.

Company Overall Sentiment
Ontrak Very Negative
Marpai Positive

Summary

Marpai beats Ontrak on 11 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OTRK vs. The Competition

MetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$7.68M$2.07B$5.37B$8.84B
Dividend YieldN/A7.23%5.09%4.09%
P/E Ratio-0.1716.00105.6017.78
Price / Sales0.683.291,246.32164.54
Price / CashN/A10.1340.1236.29
Price / Book0.673.897.066.50
Net Income-$27.92M$69.56M$119.33M$226.10M
7 Day Performance5.20%1.04%2.14%3.96%
1 Month Performance-13.74%5.20%-3.14%3.77%
1 Year Performance-78.71%-20.83%33.63%29.30%

Ontrak Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OTRK
Ontrak
2.7403 of 5 stars
$1.82
-0.5%
$45.00
+2,372.5%
-78.7%$7.68M$11.24M-0.17250Negative News
MRAI
Marpai
2.0668 of 5 stars
$1.42
+17.4%
$6.00
+322.5%
-31.7%$19.51M$37.15M-0.46150Gap Up
CCM
Concord Medical Services
0.341 of 5 stars
$4.44
-0.2%
N/A-56.0%$19.28M$471.70M0.00970
PMD
Psychemedics
0.8408 of 5 stars
$2.33
-0.4%
N/A+12.0%$13.73M$20.26M-4.59140
OPGN
OpGen
N/A$1.50
-17.1%
N/A-63.9%$12.53M$2.67M0.00100Gap Down
TOI
Oncology Institute
2.2827 of 5 stars
$0.15
flat
$2.50
+1,523.4%
-92.3%$11.63M$324.24M-0.20660Gap Up
High Trading Volume
BRTX
BioRestorative Therapies
3.4739 of 5 stars
$1.48
+2.1%
$18.00
+1,116.2%
-20.4%$10.24M$377,000.00-0.937Gap Up
ATIP
ATI Physical Therapy
0.2334 of 5 stars
$1.82
+20.5%
N/A-75.4%$8.03M$699.02M-0.105,600High Trading Volume
MGRX
Mangoceuticals
0.4525 of 5 stars
$2.65
+6.0%
N/A-97.8%$6.60M$730,000.00-0.463Gap Down
KDLY
Kindly MD
0.1695 of 5 stars
$1.08
+11.3%
N/AN/A$6.46MN/A0.00N/ALockup Expiration
Gap Up
ATPC
Agape ATP
0.0125 of 5 stars
$1.46
-4.0%
N/A-93.9%$5.81M$1.43M-2.0040

Related Companies and Tools


This page (NASDAQ:OTRK) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners